Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibrous sheath CABYR-binding protein (FSCB) is a testis- and sperm-specific protein that enables calcium ion binding, is involved in negative regulation of protein sumoylation, and is believed to function in the later stages of fibrous sheath biogenesis and spermatozoa capacitation, localizing to the sperm fibrous sheath and sperm principal piece[1][2][3][4][6]. There is no established role for FSCB as a therapeutic or diagnostic target, nor are there any known interacting drugs or mechanisms of action related to pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibrous sheath CABYR-binding protein (FSCB).